SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-459621
Filing Date
2012-11-08
Accepted
2012-11-08 11:58:01
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d417950d10q.htm 10-Q 507335
2 EX-31.1 d417950dex311.htm EX-31.1 7606
3 EX-31.2 d417950dex312.htm EX-31.2 7458
4 EX-32.1 d417950dex321.htm EX-32.1 4072
5 EX-32.2 d417950dex322.htm EX-32.2 3924
  Complete submission text file 0001193125-12-459621.txt   2319578

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtxi-20120930.xml EX-101.INS 261824
7 XBRL TAXONOMY EXTENSION SCHEMA gtxi-20120930.xsd EX-101.SCH 20449
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gtxi-20120930_cal.xml EX-101.CAL 40251
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gtxi-20120930_def.xml EX-101.DEF 22155
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gtxi-20120930_lab.xml EX-101.LAB 169515
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gtxi-20120930_pre.xml EX-101.PRE 117772
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 121189055
SIC: 2834 Pharmaceutical Preparations